Navigation Links
National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment
Date:12/4/2007

Genzyme Genetics to Provide Testing for Important Cancer and Leukemia Group

B Study

WESTBOROUGH, Mass., Dec. 4 /PRNewswire-FirstCall/ -- Genzyme Genetics, a business unit of Genzyme Corporation (Nasdaq: GENZ), announced today its participation in a Cancer and Leukemia Group B (CALGB) study sponsored by the National Cancer Institute. The multi-center study will include 1,700 newly diagnosed patients with chronic lymphocytic leukemia (CLL) and is designed to test the hypothesis that early treatment of patients with certain negative risk factors leads to longer survival. Genzyme will perform the IgVH mutation analysis for the study.

"This study is critical in helping us to understand the natural history of CLL with respect to early versus delayed progression," said John Byrd, director of hematologic malignancies & co-director, Division of Hematology- Oncology, Department of Medicine, Ohio State University and a primary investigator in the study. "We chose Genzyme to perform the IgVH analysis because of its expertise in molecular testing."

IgVH is an independent prognostic marker which can be utilized to segregate patients within all stages of CLL. Studies show that CLL patients with mutations in their IgVH gene have a longer median survival (293 months) than CLL patients without these mutations (117 months). Approximately 50 to 70 percent of patients with CLL have evidence of these mutations. The National Comprehensive Cancer Network (NCCN) recommends IgVH Mutation Analysis for patients diagnosed with CLL. The assay can be performed on either peripheral blood or bone marrow aspirate. Genzyme launched its IgVH mutation analysis test in February, 2007.

"CLL is typ
'/>"/>

SOURCE Genzyme Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
6. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
7. Arrow International Files and Mails Definitive Proxy Materials
8. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
9. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
10. Viragen International to Reverse Split Its Common Stock
11. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... FRANCISCO , March 3, 2015 Kindred Biosciences, ... on saving and improving the lives of pets, announced today ... financial results on March 12, 2015 after the market close. ... Eastern Time that day. Interested parties may ... US, or (484) 756-4262 internationally, and using conference ID 98449349.  ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research and ... addition of Jain PharmaBiotech,s new report "RNAi - ... , Because of its ability to silence ... been adopted as the research tool to discriminate gene ... RNAi can be designed to target every gene in ...
(Date:3/3/2015)... March 3, 2015  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... with a focus on protecting the microbiome, announced today that ... present at the 27th Annual ROTH Conference being held on ... in Dana Point, CA. ... 2015 at 1:00 p.m. (Pacific Time). A live ...
(Date:3/2/2015)... PA (PRWEB) March 02, 2015 The ... ReachMD announced today the launch of ... to educate healthcare professionals on the application of human ... The series features peer-to-peer interviews conducted during the ASHG ... ,     Translational Genomics and Health Outcomes Research: What's ...
Breaking Biology Technology:Global RNAi Market Report 2015 - Technologies, Markets and Companies 2014-2024 2Global RNAi Market Report 2015 - Technologies, Markets and Companies 2014-2024 3Synthetic Biologics to Present at the 27th Annual ROTH Conference 2American Society of Human Genetics (ASHG) and ReachMD Launch Series on Genetics and Genomics 2American Society of Human Genetics (ASHG) and ReachMD Launch Series on Genetics and Genomics 3
... drug,and diagnostic company, today announces that Loic Maurel, ... Chief Operating Officer. At the next,meeting of the ... du,Directoire)., Laurent Condomine, Chairman of the Supervisory ... joining ExonHit Therapeutics. His,experience and track record in ...
... − Every year, one million Europeans are confronted with ... traffic accidents. Because the nerves in a damaged spinal ... remains (partially) paralyzed. Now, VIB scientists connected to the ... simple model that enables the study of injured brain ...
... GE Energy, manufacturer of Reuter Stokes radiation detection equipment, ... electronics and software associated with the SNS 8Pack neutron ... sensitive neutron detectors developed at Oak Ridge National Laboratory. ... detection system that was developed for the Department of ...
Cached Biology Technology:Loic Maurel Joins Exonhit Therapeutics to Become CEO 2Loic Maurel Joins Exonhit Therapeutics to Become CEO 3Loic Maurel Joins Exonhit Therapeutics to Become CEO 4Microsurgery on the brain of the fruit fly leads to new insights into irreparable nerve injuries 2GE Energy to market SNS-developed detector electronics system 2
(Date:2/12/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED METHOD AND SYSTEM TO IMPROVE ... further establishes NXT-ID,s position in the emerging "Internet of ... ability for multiple devices to collaborate with one another ...
(Date:2/5/2015)... , 5. Februar 2015 Marken ... Logistikunternehmen und hat eine neue Marketingkampagne gestartet, ... (Clinical Logistics Organization – CLO) der Branche ... lautet First , mit Schwerpunkt auf ... http://photos.prnewswire.com/prnh/20150205/173753 Logo - ...
(Date:2/5/2015)... , Jan. 27, 2015   ... of globally deployed, innovative test solutions for ... the delivery of its TS-323 GENASYS ... Systems Company (LMSSC). GENASYS is a high-performance ... of mission-critical applications that require performance functional ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... which lead poisoning has struck young Rhode Island children depends ... geographic analysis of comprehensive health department data from across Rhode ... poisoning, researchers have been able to help target cleanup resources ... some census blocks in the state had no cases of ...
... predatory crabs due to global warming could threaten the ... findings. "King crabs are ecologically important predators ... said Dr Sven Thatje, an evolutionary ecologist at the ... (SOES), which is based at the National Oceanography Centre ...
... Established in 2007 and based in Toronto, ArcticDx ... its kind and specifically designed to determine one,s inherited ... form of acquired blindness in the developed world, affecting ... PBDF investment to undertake studies in support of a ...
Cached Biology News:Lead poisoning maps in R.I. reveal huge disparities, guide cleanup 2King crab distributions limited by temperature in the Southern Ocean 2OGI invests in personalized medicine for age-related macular degeneration 2
Monoclonal antibodies conjugated with rhodamine...
... [RET-P1] to Rhodopsin Rhodopsin is a ... mammals, birds, amphibians, and reptiles. The rhodopsin ... in the retina. Immunogen: ... Specificity: This antibody specifically labels ...
... 3′-(α-Amino- p- methoxyhydrocinnamamido)-3′-deoxy-N,N-dimethyladenosine, 2HCl ... FROM MOISTURE. Protein synthesis inhibitor. Inhibits ... nascent polypeptide chains. Induces DNA fragmentation ... leukemia cells. Purity: ≥98% by ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Biology Products: